Agios Pharmaceuticals (AGIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
Sales | 8,615 | 8,189 | 7,103 | 7,399 | 6,712 |
Cost of Goods | 1,495 | 627 | 586 | 633 | 1,108 |
Gross Profit | 7,120 | 7,562 | 6,517 | 6,766 | 5,604 |
Operating Expenses | 113,432 | 100,261 | 113,380 | 108,296 | 99,412 |
Operating Income | -105,817 | -92,072 | -106,277 | -100,897 | -93,700 |
Other Income | 9,699 | 10,523 | 10,337 | 9,573 | 9,894 |
Pre-tax Income | -96,118 | -81,549 | -95,940 | -91,324 | -83,806 |
Net Income Continuous | -96,118 | -81,549 | -95,940 | -91,324 | -83,806 |
Net Income | $-96,118 | $-81,549 | $-95,940 | $-91,324 | $-83,806 |
EPS Basic Total Ops | -1.69 | -1.45 | -1.71 | -1.64 | -1.51 |
EPS Basic Continuous Ops | -1.69 | -1.45 | -1.72 | -1.64 | -1.51 |
EPS Diluted Total Ops | -1.69 | -1.45 | -1.71 | -1.64 | -1.51 |
EPS Diluted Continuous Ops | -1.69 | -1.45 | -1.72 | -1.64 | -1.51 |
EPS Diluted Before Non-Recurring Items | -1.69 | -1.45 | -1.72 | -1.64 | -1.51 |
EBITDA(a) | $-106,833 | $-93,251 | $-105,267 | $-98,194 | $-94,855 |